Please assess the completion status of the following clinical trial:

Trial Title: Transcranial Magnetic Stimulation Treatment for Generalized Anxiety Disorder

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Diagnosed with GAD as the principal or co-principal disorder~* Clinical Global Impression Score ≥ 4~* Hamilton Anxiety Rating Scale ≥ 18~* Hamilton Rating Scale for Depression ≤ 17~* Fluency in English~* Capacity to understand the nature of the study and willingness to sign informed consent form.~Exclusion Criteria:~* History of epilepsy or head trauma (LOC \> 5 minutes) within the past 6 months.~* Lifetime history of increased intracranial pressure, seizure disorder, stroke, brain tumor, multiple sclerosis, or brain surgery.~* A review of patient medications by the study physician indicates an increased risk of seizure.~* An active autoimmune, endocrine, viral, or vascular disorder affecting the brain; any unstable cardiac disease; hypertension; or severe renal or liver insufficiency.~* Substance use disorder or PTSD within the past 6 months.~* Lifetime bipolar disorder, obsessive-compulsive disorder (OCD), psychotic disorder, mental retardation, or pervasive developmental disorder.~* Any psychotic features, including dementia or delirium. Concurrent psychotherapy and unwillingness to discontinue~* Medication change within past 3 months.~* Current serious suicidal or homicidal ideation, and/or serious suicidal attempt within past 6 months.~* Serious, unstable, or terminal medical condition or clinically judged too psychiatrically unstable to participate in the study.~* Any contraindication for participation in MRI scan

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- TMS Therapy (Type: EXPERIMENTAL): TMS treatment
- TMS-Sham (Type: SHAM_COMPARATOR): This is a sham TMS condition

Based on this trial design, predict the completion outcome and termination type (if applicable).